Recurrence of Epithelioid Hemangioendothelioma during Pregnancy: Case Report and Systematic Review
Author(s) -
Michael McCulloch,
Michael Russin,
Arian Nachat
Publication year - 2016
Publication title -
the permanente journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.445
H-Index - 30
eISSN - 1552-5775
pISSN - 1552-5767
DOI - 10.7812/tpp/15-152
Subject(s) - medicine , epithelioid hemangioendothelioma , vascular endothelial growth factor , placental growth factor , sunitinib , pregnancy , sorafenib , angiogenesis , thalidomide , oncology , pathology , renal cell carcinoma , vegf receptors , immunohistochemistry , hepatocellular carcinoma , multiple myeloma , genetics , biology
Epithelioid hemangioendothelioma (EHE) is a family of blood vessel tumors originating in blood vessels, bone, brain, kidney, liver, and lung. EHE is more common in women, and chemotherapy, radiation, and surgery have brought few successes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom